ADC Therapeutics SA (ADCT)
4.83
+0.38
(+8.54%)
USD |
NYSE |
May 07, 16:00
4.72
-0.11
(-2.28%)
After-Hours: 20:00
ADC Therapeutics Shareholders Equity (Quarterly): -148.25M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -148.25M |
| September 30, 2023 | -54.18M |
| June 30, 2023 | -8.589M |
| March 31, 2023 | 37.68M |
| December 31, 2022 | 79.45M |
| September 30, 2022 | 104.78M |
| June 30, 2022 | 115.35M |
| March 31, 2022 | 162.67M |
| December 31, 2021 | 166.09M |
| Date | Value |
|---|---|
| September 30, 2021 | 187.31M |
| June 30, 2021 | 243.92M |
| March 31, 2021 | 297.97M |
| December 31, 2020 | 335.50M |
| September 30, 2020 | 376.06M |
| June 30, 2020 | 196.30M |
| December 31, 2019 | 111.16M |
| June 30, 2019 | 177.99M |
| December 31, 2018 | 126.24M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-148.25M
Minimum
Dec 2023
376.06M
Maximum
Sep 2020
140.07M
Average
162.67M
Median
Mar 2022
Shareholders Equity (Quarterly) Benchmarks
| Roche Holding AG | 34.90B |
| Novartis AG | 39.68B |
| AC Immune SA | 191.25M |
| CRISPR Therapeutics AG | 1.883B |
| Addex Therapeutics Ltd | 1.364M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 354.78M |
| Total Liabilities (Quarterly) | 503.03M |
| Debt to Equity Ratio | -0.7604 |
| Current Ratio | 4.970 |
| Net Debt Paydown Yield | -0.52% |